SPOTLIGHT: Fast growth for vaccine market


RNCOS estimates that the global vaccines market should hit $21 billion by 2010. Analysts say that the vaccine market has been growing at a much faster clip than pharma in general. Release

Suggested Articles

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.

Ebola has claimed thousands of lives in recent outbreaks, but now the world has a licensed vaccine option in Merck's Ervebo.

Cosette Pharmaceuticals which was formed in December with a deal for dermatology projects has gone back to G&W Labs for a liquids plant.